Parkinson's Disease
Conditions
Brief summary
By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.
Interventions
OTHERThere is no intervention, this is a biorepository.
There are no interventions in this study.
Sponsors
Scripps Health
The Scripps Research Institute
Scripps Translational Science Institute
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Is age 30 years or older at the time of onset of Parkinson's * Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist * Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so * Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so
Exclusion criteria
* Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry * If a blood draw would be contraindicated for any reason * Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study * Treatment with any investigational agents or devices within 30 days preceding enrollment in the study * Has undergone ECT within 90 days preceding enrollment in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Neurogenetic databank | Study completion | initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions. |
Countries
United States
Outcome results
None listed